Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.765 USD | +0.36% | +2.73% | +0.72% |
Financials (USD)
Sales 2024 * | 206M | Sales 2025 * | 243M | Capitalization | 884M |
---|---|---|---|---|---|
Net income 2024 * | 19M | Net income 2025 * | 30M | EV / Sales 2024 * | 4.03 x |
Net cash position 2024 * | 56.09M | Net cash position 2025 * | 92.97M | EV / Sales 2025 * | 3.25 x |
P/E ratio 2024 * |
79
x | P/E ratio 2025 * |
46.8
x | Employees | 1,102 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.33% |
Latest transcript on Enfusion, Inc.
1 day | +0.41% | ||
1 week | +3.05% | ||
Current month | +5.26% | ||
1 month | +2.08% | ||
3 months | +20.54% | ||
6 months | +9.87% | ||
Current year | +1.03% |
Managers | Title | Age | Since |
---|---|---|---|
Oleg Movchan
FOU | Founder | 50 | 05-12-31 |
Bradley Herring
DFI | Director of Finance/CFO | 54 | 22-12-18 |
Dan Groman
CTO | Chief Tech/Sci/R&D Officer | 35 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kathleen DeRose
BRD | Director/Board Member | 63 | 21-12-06 |
Brad Bernstein
BRD | Director/Board Member | 57 | 20-12-31 |
Director/Board Member | 63 | 19-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 0 M€ | +8.42% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 9.77 | +0.41% | 68 329 |
24-05-07 | 9.73 | -0.51% | 259,873 |
24-05-06 | 9.78 | +2.19% | 421,891 |
24-05-03 | 9.57 | +0.53% | 255,937 |
24-05-02 | 9.52 | +0.11% | 237,455 |
Delayed Quote Nyse, May 08, 2024 at 12:46 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.03% | 884M | |
+9.32% | 3,042B | |
+6.76% | 83.84B | |
+4.03% | 77.3B | |
-13.64% | 53.92B | |
-24.99% | 47.93B | |
+24.64% | 47.66B | |
+20.48% | 43.81B | |
+60.77% | 37.42B | |
-14.20% | 25.93B |
- Stock Market
- Equities
- ENFN Stock